Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
105.39
Dollar change
-3.84
Percentage change
-3.52
%
Index- P/E- EPS (ttm)-1.23 Insider Own16.48% Shs Outstand24.14M Perf Week1.74%
Market Cap2.54B Forward P/E15.87 EPS next Y6.64 Insider Trans-29.55% Shs Float20.16M Perf Month15.14%
Income-29.66M PEG- EPS next Q0.82 Inst Own89.79% Short Float5.04% Perf Quarter24.52%
Sales2.26B P/S1.13 EPS this Y-30.14% Inst Trans-3.33% Short Ratio3.45 Perf Half Y-28.66%
Book/sh87.95 P/B1.20 EPS next Y40.66% ROA-0.67% Short Interest1.02M Perf Year-37.48%
Cash/sh10.55 P/C9.99 EPS next 5Y16.00% ROE-1.41% 52W Range78.28 - 212.43 Perf YTD5.66%
Dividend Est.- P/FCF30.91 EPS past 5Y- ROI-0.79% 52W High-50.39% Beta0.70
Dividend TTM- Quick Ratio1.06 Sales past 5Y13.31% Gross Margin31.39% 52W Low34.63% ATR (14)4.71
Dividend Ex-Date- Current Ratio2.53 EPS Y/Y TTM60.56% Oper. Margin1.26% RSI (14)55.17 Volatility5.40% 4.26%
Employees14000 Debt/Eq0.80 Sales Y/Y TTM-0.91% Profit Margin-1.31% Recom1.80 Target Price136.00
Option/ShortYes / Yes LT Debt/Eq0.77 EPS Q/Q-9.66% Payout- Rel Volume1.51 Prev Close109.23
Sales Surprise2.27% EPS Surprise31.66% Sales Q/Q1.93% EarningsFeb 27 AMC Avg Volume293.90K Price105.39
SMA203.86% SMA506.99% SMA200-17.93% Trades Volume443,486 Change-3.52%
Date Action Analyst Rating Change Price Target Change
Nov-08-22Downgrade Raymond James Outperform → Mkt Perform
Mar-31-20Upgrade CJS Securities Market Perform → Market Outperform
Mar-18-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $206
Aug-08-19Downgrade Raymond James Strong Buy → Outperform
Oct-17-17Initiated KeyBanc Capital Mkts Sector Weight
Jun-20-17Downgrade Sidoti Buy → Neutral
Mar-11-16Initiated Gabelli & Co Buy $128
Nov-06-15Reiterated ROTH Capital Buy $124 → $130
Aug-11-15Reiterated ROTH Capital Buy $102 → $124
May-06-15Reiterated ROTH Capital Buy $96 → $102
Mar-01-24 05:15PM
Feb-28-24 07:48PM
09:49AM
09:36AM
Feb-27-24 06:20PM
05:21PM Loading…
05:21PM
04:36PM
04:05PM
Feb-20-24 10:00AM
Feb-14-24 11:18PM
Feb-13-24 09:02AM
08:30AM
Nov-27-23 06:28PM
Nov-07-23 10:36AM
Nov-06-23 11:37PM
05:23PM Loading…
05:23PM
05:17PM
04:05PM
Oct-27-23 09:06PM
Oct-23-23 08:30AM
Sep-25-23 08:40AM
Sep-12-23 01:01AM
Sep-05-23 08:30AM
Sep-04-23 09:34AM
Aug-29-23 08:00AM
Aug-09-23 07:01AM
Aug-08-23 07:36PM
06:31AM
Aug-07-23 08:13PM
06:40PM
05:31PM Loading…
05:31PM
04:05PM
Jul-24-23 08:30AM
Jun-21-23 08:00PM
Jun-20-23 05:13PM
May-10-23 06:09AM
May-09-23 05:25PM
05:57AM
May-08-23 05:35PM
04:29PM
04:05PM
Apr-26-23 08:00PM
Apr-24-23 07:56PM
08:30AM
Apr-11-23 07:07AM
Mar-29-23 09:47AM
Mar-15-23 05:55PM
Mar-09-23 08:30AM
Mar-02-23 05:44AM
Mar-01-23 07:11PM
05:15AM
Feb-28-23 11:05AM
06:31AM
Feb-27-23 06:15PM
04:05PM
Feb-26-23 08:04AM
Feb-21-23 08:30AM
Feb-13-23 08:30AM
Feb-08-23 08:00AM
Jan-23-23 08:55AM
Jan-20-23 07:21PM
Dec-19-22 08:30AM
Dec-03-22 07:28AM
Nov-07-22 06:35PM
04:05PM
Nov-06-22 07:21AM
Nov-01-22 09:00AM
Oct-31-22 04:01PM
Oct-07-22 10:08AM
Oct-06-22 08:30AM
Sep-26-22 08:18AM
Sep-08-22 08:30AM
Aug-09-22 03:15PM
Aug-08-22 06:15PM
04:05PM
Jul-19-22 08:30AM
Jun-18-22 08:51AM
May-19-22 08:05AM
May-11-22 04:12PM
May-09-22 05:45PM
04:05PM
06:07AM
May-06-22 03:18AM
May-05-22 02:52AM
May-04-22 03:05AM
Apr-20-22 08:30AM
03:35AM
Apr-19-22 07:51AM
02:57AM
Apr-14-22 02:37AM
Apr-13-22 06:54AM
Apr-12-22 02:31AM
Apr-11-22 05:04AM
Apr-08-22 02:37AM
Mar-24-22 08:03AM
Mar-23-22 12:00PM
09:40AM
06:53AM
Mar-22-22 12:45PM
Mar-14-22 08:30AM
ICU Medical, Inc. develops, manufactures, and sells innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SMITHS GROUP PLCFormer 10% OwnerFeb 29Sale106.08830,00088,042,2501,670,000Mar 01 04:16 PM
Smiths Group International HolFormer 10% OwnerFeb 29Sale106.08830,00088,042,2501,670,000Mar 01 04:16 PM
Jain VivekChairman and CEOFeb 12Option Exercise58.79146,3668,604,857170,043Feb 14 04:23 PM
Jain VivekChairman and CEOFeb 12Option Exercise58.7966,0003,880,140126,000Feb 14 04:23 PM
Woolson DanielVP, GM-Infusion CapitalDec 01Sale88.031,729152,1969,877Dec 01 05:08 PM
Voigtlander Christian B.Chief Operating OfficerSep 08Sale129.046,850883,93013,603Sep 11 12:27 PM
Jain VivekChairman and CEOJul 12Option Exercise58.7930,0001,763,70053,677Jul 14 05:36 PM
Jain VivekChairman and CEOJul 12Sale180.0230,0005,400,72023,677Jul 14 05:36 PM
Jain VivekChairman and CEOJun 14Option Exercise58.7930,0001,763,70031,840Jun 15 10:22 AM
Jain VivekChairman and CEOJun 14Sale188.6730,0005,660,08623,677Jun 15 10:22 AM
FINNEY ELISHA WDirectorJun 07Sale190.4119436,9401,481Jun 07 04:26 PM
KENNEDY KOLLEEN TDirectorMay 17Option Exercise0.004850614May 18 12:51 PM
Hoffmeister David FDirectorMay 17Option Exercise0.0048502,079May 18 12:46 PM
FINNEY ELISHA WDirectorMay 17Option Exercise0.0048501,675May 18 12:41 PM
Abbey DonaldDirectorMay 17Option Exercise0.0048502,079May 18 12:37 PM
Hernandez LaurieDirectorMay 17Option Exercise0.004850937May 18 12:19 PM
Greenberg David C.DirectorMay 17Option Exercise0.0048504,089May 18 12:15 PM
Sanzone Virginia RuthVP, General CounselApr 11Sale175.0025043,7504,678Apr 11 02:11 PM
Sanzone Virginia RuthVP, General CounselApr 05Sale170.0045877,8604,928Apr 05 05:07 PM
Sanzone Virginia RuthVP, General CounselMar 08Option Exercise0.002,27206,582Mar 08 05:06 PM
Woolson DanielVP, GM-Infusion CapitalMar 08Option Exercise0.002,020012,500Mar 08 05:09 PM
Voigtlander Christian B.Chief Operating OfficerMar 08Option Exercise0.002,209021,616Mar 08 04:59 PM
Jain VivekChairman and CEOMar 08Option Exercise0.002,525025,091Mar 08 04:56 PM
Bonnell Brian MichaelChief Financial OfficerMar 08Option Exercise0.002,209013,578Mar 08 04:52 PM
Bonnell Brian MichaelChief Financial OfficerMar 07Option Exercise0.002,145012,498Mar 08 04:52 PM
Jain VivekChairman and CEOMar 07Option Exercise0.003,218024,260Mar 08 04:56 PM
Voigtlander Christian B.Chief Operating OfficerMar 07Option Exercise0.002,145020,536Mar 08 04:59 PM
Woolson DanielVP, GM-Infusion CapitalMar 07Option Exercise0.00965010,908Mar 08 05:09 PM
Sanzone Virginia RuthVP, General CounselMar 07Option Exercise0.001,07204,874Mar 08 05:06 PM
Sanzone Virginia RuthVP, General CounselMar 06Option Exercise0.001,59504,641Mar 08 05:06 PM
Woolson DanielVP, GM-Infusion CapitalMar 06Option Exercise0.001,417010,569Mar 08 05:09 PM
Voigtlander Christian B.Chief Operating OfficerMar 06Option Exercise0.0010,296022,260Mar 08 04:59 PM
Jain VivekChairman and CEOMar 06Option Exercise0.0011,767026,303Mar 08 04:56 PM
Bonnell Brian MichaelChief Financial OfficerMar 06Option Exercise0.0010,296014,957Mar 08 04:52 PM